New RA Drug Tofacitinib – The String Runs Out
An FDA panel approved another new pharmaceutical to defeat the immune system, for use as a last resort by Rheumatoid Arthritis patients who don’t respond to other drugs. The drug, tofacitinib, made by Pfizer, is expected to earn the company billions, just as some of their other blockbusters, like Vi